BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 38593345)

  • 21. Advancing therapeutics using antibody-induced dimerization of receptor tyrosine phosphatases.
    Tremblay ML
    Genes Dev; 2023 Aug; 37(15-16):678-680. PubMed ID: 37673461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparan sulfate proteoglycans and cancer.
    Blackhall FH; Merry CL; Davies EJ; Jayson GC
    Br J Cancer; 2001 Oct; 85(8):1094-8. PubMed ID: 11710818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.
    Farach-Carson MC; Warren CR; Harrington DA; Carson DD
    Matrix Biol; 2014 Feb; 34():64-79. PubMed ID: 24001398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparan Sulfate in the Tumor Microenvironment.
    Bartolini B; Caravà E; Caon I; Parnigoni A; Moretto P; Passi A; Vigetti D; Viola M; Karousou E
    Adv Exp Med Biol; 2020; 1245():147-161. PubMed ID: 32266657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenascin-contactin/F11 interactions: a clue for a developmental role?
    Vaughan L; Weber P; D'Alessandri L; Zisch AH; Winterhalter KH
    Perspect Dev Neurobiol; 1994; 2(1):43-52. PubMed ID: 7530143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparan sulfate in the nucleus and its control of cellular functions.
    Stewart MD; Sanderson RD
    Matrix Biol; 2014 Apr; 35():56-9. PubMed ID: 24309018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
    Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
    J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific structural features of syndecans and heparan sulfate chains are needed for cell signaling.
    Lopes CC; Dietrich CP; Nader HB
    Braz J Med Biol Res; 2006 Feb; 39(2):157-67. PubMed ID: 16470302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-associated point mutations within the extracellular domain of PTPRD affect protein stability and HSPG interaction.
    Matsui Y; Imai A; Izumi H; Yasumura M; Makino T; Shimizu T; Sato M; Mori H; Yoshida T
    FASEB J; 2024 Apr; 38(7):e23609. PubMed ID: 38593345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.
    Uhl GR; Martinez MJ
    Ann N Y Acad Sci; 2019 Sep; 1451(1):112-129. PubMed ID: 30648269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Morphology of basement membrane and associated matrix proteins in normal and pathological tissues].
    Nerlich A
    Veroff Pathol; 1995; 145():1-139. PubMed ID: 8638427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities.
    Lanzi C; Cassinelli G
    Biochem Pharmacol; 2020 Aug; 178():114084. PubMed ID: 32526230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein tyrosine phosphatase σ in proteoglycan-mediated neural regeneration regulation.
    Chien PN; Ryu SE
    Mol Neurobiol; 2013 Feb; 47(1):220-7. PubMed ID: 22956273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.